CLS Americas Announces 2nd Order of TRANBERG™ Focal Laser Ablation Accessories Placed by the National Institutes of Health Clinical Center
April 09, 2024 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas received its second order from the National Institutes of Health Clinical Center (NIHCC) for its TRANBERG Thermal Therapy System accessories.
CLS Americas Announces ROSE Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation
March 28, 2024 00:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
– CLS Americas today announcedthat ROSE Urology, LLC will begin using the TRANBERG™ Thermal Therapy System to treat prostate cancer patients.
CLS Americas Selects Quest International to Provide Aftermarket Service and Logistics Operations for TRANBERG Laser Ablation System
November 28, 2023 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas selects Quest International, a global aftermarket technical service provider to OEMs, to provide Service and Logistics to the US market.
CLS Americas States KASRAEIAN Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation
November 09, 2023 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas today announced that KASRAEIAN Urology located in Jacksonville, FL, will begin treating prostate cancer patients using the TRANBERG™ Laser.
CLS Americas and HALO Diagnostics Initiate Prostate Cancer Clinical Study using TRANBERG Focal Laser Ablation System
November 07, 2023 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
CLS,and HALO Diagnostics announce 25-patient clinical study using the TRANBERG™ System to perform focal laser ablation on prostate cancer patients.
CLS Americas Announces Kearney Urology Center will use its TRANBERG Laser to Provide Focal Laser Ablation Treatments to Prostate Cancer Patients
October 24, 2023 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas announces Kearney Urology Center will use its TRANBERG Laser to treat prostate cancer patients.
CLS Americas Debuts Mobile Service Program for Office-Based Focal Laser Ablation at Western Section AUA Meeting
October 03, 2023 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas Debuts Mobile Service Program for Office-Based Focal Laser Ablation at Western Section AUA Meeting
CLS Americas Presents its TRANBERG™ System for Image-Guided Focal Laser Ablation at Focal Therapy Society 2023 Conference
September 07, 2023 08:49 ET
|
Clinical Laserthermia Systems Americas, Inc.
WASHINGTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- CLS Americas, a leading provider of office-based, focal laser ablation systems in the US urology market, today announced it will exhibit its TRANBERG™...
CLS Americas and Focalyx Co-Marketing Agreement for Image-Guided Focal Laser Ablation of Prostate Tumors Using TRANBERG and Focalyx Fusion Systems
August 28, 2023 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and MIAMI, Aug. 28, 2023 (GLOBE NEWSWIRE) -- CLS Americas, a leading provider of office-based, focal laser ablation systems in the US urology market, and Focalyx® today announced a...
CLS Americas Announces the National Institutes of Health Clinical Center Placed its 1st Order of the TRANBERG™ Thermal Therapy System for its Research Study - MRI/Ultrasound Fusion-Guided FLA of Prostate Tissue and Prostate Cancer
June 01, 2023 02:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today...